Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer by Shao-Jing Wang, Lou Sun, Yu-Hsiang Shih, Ting-Fang Lu, Yen-Fu Chen, Shih-Tien Hsu, Chin-Ku Liu, Sheau-Feng Hwang, Jem-Kun Chen, Hsin-Hua Chen, Chien-Hsing Lu

Get full text